{
    "code": "52027053",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027053",
    "time": "2022-07-08 04:17:56",
    "許可證字號": "衛部藥輸字第027053號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/04\/14",
    "發證日期": "106\/04\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202705302",
    "中文品名": "美加柔持續性藥效膜衣錠150毫克",
    "英文品名": "Megazon Prolonged-Release Tablets 150mg",
    "適應症": "治療思覺失調症、雙極性疾患之鬱症發作、躁症發作或混合發作。對於抗鬱劑單一藥物治療效果不佳的重鬱症（MDD）病人，可作為重鬱症發作的附加治療。開始治療之前，臨床醫師應該考慮Quetiapine XR的安全性。",
    "劑型": "164持續性藥效膜衣錠",
    "包裝": "2-1000錠PVC\/PCTFE\/Alu鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新使用劑量",
    "監視期限": "",
    "主成分略述": "QUETIAPINE FUMARATE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "620110S434  西海生技股份有限公司",
    "申請商地址": "臺北市中山區民權東路二段46號10樓之2",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0044000  PHARMATHEN INTERNATIONAL S.A.",
            "製造廠廠址": "INDUSTRIAL PARK, 5TH BLOCK, 69300, SAPES, RODOPI, GREECE",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037620",
            "成分名稱": "QUETIAPINE FUMARATE",
            "含量描述": "(equivalent to Quetiapine.....150mg)",
            "含量": "172.6800000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "MEGAZON PRT 150mg_tab front+back_Apr 2017_-106-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027053&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "04. 附件四_美加柔持續錠性藥效膜衣錠仿單電子檔(50&150&200&300毫克合併仿單)-111-06-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027053&Seq=003&Type=9"
        },
        {
            "title": "020270530004_MEGAZON PRT 150mg_CN sticker_Apr 2017-106-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027053&Seq=003&Type=8"
        },
        {
            "title": "020270530003_MEGAZON PRT 150mg_box_Apr 2017-106-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027053&Seq=002&Type=8"
        },
        {
            "title": "020270530002_MEGAZON PRT 150mg_foil_Apr 2017-106-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027053&Seq=001&Type=8"
        }
    ]
}